Loading...
Images of Tsuma Ian Krop
(0 from 0 )News
SABCS 2014: PI3K Inhibition With Pictilisib in Hormone...
ascopost.com
... –positive breast cancer holds true in an additional cohort of patients within this study,” stated lead author Ian Krop, MD, ...
Ado-trastuzumab emtansine significantly extended OS in HER-2–positive...
www.healio.com
Ian Krop. Ian E. Krop. Ian E. Krop, MD, of the department of medical oncology at Dana-Farber Cancer Institute and Harvard University School of ...
Right pathway, wrong drug? Roche's pictilisib trips up - PharmaTimes
www.pharmatimes.com
... investigator of the FERGI study, Ian Krop of the Dana-Farber Cancer Institute, speaking at the recent San Antonio Breast Cancer conference.
Experimental Immune Therapy Tested in Preliminary Study of Women with...
www.hopkinsmedicine.org
Early data in a preliminary human study show that an experimental immune system drug is generally safe and well tolerated in women with metastatic,...
sorted by relevance / date